Immunosoppressore: differenze tra le versioni
Contenuto cancellato Contenuto aggiunto
Nessun oggetto della modifica |
m r2.7.1) (Bot: Aggiungo ar, ca, cs, de, es, eu, fr, hu, ja, nl, pl, ru, simple, sl, sr, sv, zh |
||
Riga 42:
* Woolacott N et al. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess. 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239.
* Edrees AF, Misra SN, Abdou NI. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol. 2005 Jul-Aug; 23(4):469-74.
[[en:Immunosuppressive drug]]▼
{{Portale|biologia|medicina}}
[[Categoria:Agenti immunosoppressivi]]
[[ar:ادوية كبت المناعة]]
[[ca:Immunosupressor]]
[[cs:Imunosupresivum]]
[[de:Immunsuppressivum]]
▲[[en:Immunosuppressive drug]]
[[es:Inmunosupresor]]
[[eu:Immunosupresore]]
[[fr:Immunosuppresseur]]
[[hu:Immunszupresszív gyógyszerek]]
[[ja:免疫抑制剤]]
[[nl:Immuunsuppressivum]]
[[pl:Leki immunosupresyjne]]
[[ru:Иммунодепрессанты]]
[[simple:Immunosuppressant drugs]]
[[sl:Imunosupresiv]]
[[sr:Imunosupresivi]]
[[sv:Immunosuppressiva läkemedel]]
[[zh:免疫抑制药]]
| |||